Europe news

As the Emergency Situation in Latvija is extended until 7 February, Latvian Medicines Verification Organization (LZVO) will work in a mixed mode, both remotely and on-site.

A new board member Evita Jaunzeme, who is representing manufacturers of innovative medicinal products (Association of International Innovative Pharmaceuticals Producers) and manufacturers of generic medicinal products (Latvian Generic Medicines Association), has been appointed on the board of Latvian Medicines Verification Organisation (LZVO) since December 8, 2020. E. Jaunzeme is Gedeon Richter Plc. Head of the Representation in Latvia.

In order to continuously maintain the security of the Latvian medicines verification system, it is necessary to renew the initially installed safety certificates every 2 years for all users connected to it.

European Medicines Verification Organisation (EMVO) was published frequently asked questions regarding verification system and Brexit.

The Latvian medicines verification system, continuing its work and all its users performing their duties, 1.94 million packs of medicines have been verified and dispensed from the system during October.

In October, 7 new users have joined the Latvian medicines verification system (LZVS), thus a total of 1257 system end users have joined the system in Latvia and the safety of medicines can be verified by them.

Attesting their qualification and high operating standards of the LZVO, more and more specialists of the Latvian Medicines Verification Organisation (LZVO) hold positions at the international level.

EMVO has been working to manage the implications of Brexit (the UK’s departure from the EU Internal Market rules) for the EMVS and its users.

Latvian Medicines Verification Organization (LZVO) will work in a mixed mode from 9 November to 6 December